The risk of mortality among young children hospitalized for severe respiratory syncytial virus infection

被引:0
|
作者
Szabo, Shelagh M. [1 ]
Gooch, Katherine L. [2 ]
Bibby, Meagan M. [1 ]
Vo, Pamela G. [2 ]
Mitchell, Ian [3 ,4 ]
Bradt, Pamela
Levy, Adrian R. [1 ,5 ]
机构
[1] Oxford Outcomes, Vancouver, BC, Canada
[2] Abbott Labs, Abbott Pk, IL 60064 USA
[3] Univ Calgary, Calgary, AB, Canada
[4] Alberta Childrens Prov Gen Hosp, Calgary, AB T2T 5C7, Canada
[5] Dalhousie Univ, Dept Epidemiol & Community Hlth, Halifax, NS, Canada
关键词
Respiratory syncytial virus; Fatality; Hospitalization; Review; systematic; CONGENITAL HEART-DISEASE; INVESTIGATORS COLLABORATIVE NETWORK; RSV IMMUNE GLOBULIN; CLINICAL CHARACTERISTICS; PALIVIZUMAB PROPHYLAXIS; PRETERM INFANTS; EPIDEMIOLOGY; BURDEN; AGE; REHOSPITALIZATION;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) is the leading cause of childhood morbidity. Although also an important cause of childhood mortality worldwide, the impact of key risk factors has not been established. A systematic review of 34 articles reporting case fatality rates in young children hospitalized for severe RSV LRTI, according to the presence of underlying RSV risk factors, was conducted. The weighted mean case fatality rate was 1.2% (range, 0-8.3%; median, 0%; n = 10) among preterm infants; 5.2% (range, 2.0-37.0%; median, 5.9%; n = 7) among children with CHD; and 4.1% (range, 0-10.5%; median, 7.0%; n = 6) among children with BPD. Case fatality estimates among children not at high risk (n = 6) ranged from 0% to 1.5% (weighted mean, 0.2%; median, 0.0%). Fatality during hospitalization for severe RSV LRTI is rare among children not at high risk, but occurs more commonly among children at higher risk of RSV LRTI. (c) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:S1 / S8
页数:8
相关论文
共 50 条
  • [21] The Burden of Respiratory Syncytial Virus Infection in Young Children
    Hall, Caroline Breese
    Weinberg, Geoffrey A.
    Iwane, Marika K.
    Blumkin, Aaron K.
    Edwards, Kathryn M.
    Staat, Mary A.
    Auinger, Peggy
    Griffin, Marie R.
    Poehling, Katherine A.
    Erdman, Dean
    Grijalva, Carlos G.
    Zhu, Yuwei
    Szilagyi, Peter
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (06): : 588 - 598
  • [22] Respiratory syncytial virus infection in infants and young children
    Levy, BT
    Graber, MA
    [J]. JOURNAL OF FAMILY PRACTICE, 1997, 45 (06): : 473 - 481
  • [23] Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases
    Paolo Manzoni
    Josep Figueras-Aloy
    Eric A. F. Simões
    Paul A. Checchia
    Brigitte Fauroux
    Louis Bont
    Bosco Paes
    Xavier Carbonell-Estrany
    [J]. Infectious Diseases and Therapy, 2017, 6 : 383 - 411
  • [24] Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases
    Manzoni, Paolo
    Figueras-Aloy, Josep
    Simoes, Eric A. F.
    Checchia, Paul A.
    Fauroux, Brigitte
    Bont, Louis
    Paes, Bosco
    Carbonell-Estrany, Xavier
    [J]. INFECTIOUS DISEASES AND THERAPY, 2017, 6 (03) : 383 - 411
  • [25] Anticipated costs of hospitalization for respiratory syncytial virus infection in young children at risk
    Rietveld, E
    de Jonge, HCC
    Polder, JJ
    Vergouwe, Y
    Veeze, HJ
    Moll, HA
    Steyerberg, EW
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (06) : 523 - 529
  • [26] Risk factors of severe hospitalized respiratory syncytial virus infection in tertiary care center in Thailand
    Aikphaibul, Puneyavee
    Theerawit, Tuangtip
    Sophonphan, Jiratchaya
    Wacharachaisurapol, Noppadol
    Jitrungruengnij, Nattapong
    Puthanakit, Thanyawee
    [J]. INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2021, 15 (01) : 64 - 71
  • [27] Clinical characteristics of respiratory syncytial virus infection in hospitalized healthy infants and young children in Qatar
    Wahab, AA
    Dawod, ST
    Raman, HMA
    [J]. JOURNAL OF TROPICAL PEDIATRICS, 2001, 47 (06) : 363 - 366
  • [29] Evaluation of the safety of palivizumab in the second season of exposure in young children at risk for severe respiratory syncytial virus infection
    Lacaze-Masmonteil, T
    Seidenberg, J
    Mitchell, I
    Cossey, V
    Cihar, M
    Csader, M
    Baarsma, R
    Valido, M
    Pollack, PF
    Groothuis, JR
    [J]. DRUG SAFETY, 2003, 26 (04) : 283 - 291
  • [30] Evaluation of the Safety of Palivizumab in the Second Season of Exposure in Young Children at Risk for Severe Respiratory Syncytial Virus Infection
    Thierry Lacaze-Masmonteil
    Juergen Seidenberg
    Ian Mitchell
    Veerle Cossey
    Martin Cihar
    Michal Csader
    Rienk Baarsma
    Marques Valido
    Paul F. Pollack
    Jessie R. Groothuis
    [J]. Drug Safety, 2003, 26 : 283 - 291